Femoral Proximal Articles & Analysis: Older
1 articles found
” In May 2020, Alucent initiated a small, Phase I human safety study (ACTIVATE I) of NVS for PAD in the superficial femoral and/or proximal popliteal artery; that study is partly enrolled and will likely need to await resolution of the COVID-19 pandemic before completion. ...